MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
XNCR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Xencor (XNCR) Ownership - Who owns Xencor?

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
465 North Halstead Street
Phone
+1 626 305-5900
Employees
256
Web
https://www.xencor.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.04B
P/E Ratio
N/A
Total Cash
444.95M
Projected Growth
N/A
Total Debt
175.16M
Revenue
97.36M
Risk (Beta)
1.26
Dividend Yield
N/A
Total Cash/Share
6.00
Total Debt/Equity
N/A
Revenue/Share
1.30 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
XNCR
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for XNCR
A.I. Advisor
published General Information

General Information

a developer of therapeutics to treat autoimmune and allergic diseases, cancer and other conditions

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
465 North Halstead Street
Phone
+1 626 305-5900
Employees
256
Web
https://www.xencor.com